EP4203952A4 - Composés hétérocycliques et leurs utilisations - Google Patents
Composés hétérocycliques et leurs utilisations Download PDFInfo
- Publication number
- EP4203952A4 EP4203952A4 EP21862890.7A EP21862890A EP4203952A4 EP 4203952 A4 EP4203952 A4 EP 4203952A4 EP 21862890 A EP21862890 A EP 21862890A EP 4203952 A4 EP4203952 A4 EP 4203952A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063072056P | 2020-08-28 | 2020-08-28 | |
| PCT/US2021/048101 WO2022047260A1 (fr) | 2020-08-28 | 2021-08-27 | Composés hétérocycliques et leurs utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4203952A1 EP4203952A1 (fr) | 2023-07-05 |
| EP4203952A4 true EP4203952A4 (fr) | 2024-12-11 |
Family
ID=80353317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21862890.7A Pending EP4203952A4 (fr) | 2020-08-28 | 2021-08-27 | Composés hétérocycliques et leurs utilisations |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20230331717A1 (fr) |
| EP (1) | EP4203952A4 (fr) |
| JP (1) | JP2023540270A (fr) |
| CN (1) | CN116368130A (fr) |
| AU (1) | AU2021331492A1 (fr) |
| CA (1) | CA3191279A1 (fr) |
| WO (1) | WO2022047260A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023009278A (es) * | 2021-02-09 | 2023-08-17 | Usynova Pharmaceuticals Ltd | Compuestos ciclicos aromaticos pirimidina. |
| WO2022214102A1 (fr) * | 2021-04-09 | 2022-10-13 | 杭州英创医药科技有限公司 | Composé hétérocyclique agissant comme inhibiteur de kras g12d |
| AU2022265682A1 (en) * | 2021-04-29 | 2023-11-09 | Amgen Inc. | 2-aminobenzothiazole compounds and methods of use thereof |
| CN117222650A (zh) * | 2021-04-30 | 2023-12-12 | 劲方医药科技(上海)有限公司 | 吡啶或嘧啶并环类化合物，其制法与医药上的用途 |
| CN117500799A (zh) * | 2021-06-09 | 2024-02-02 | 伊莱利利公司 | 作为kras g12d抑制剂的取代的稠合吖嗪 |
| AU2022288151A1 (en) * | 2021-06-10 | 2024-01-18 | Redx Pharma Plc | Quinazoline derivatives useful as ras inhibitiors |
| US20240409558A1 (en) * | 2021-09-13 | 2024-12-12 | Biomea Fusion, Inc. | Irreversible inhibitors of kras |
| WO2023061294A1 (fr) * | 2021-10-13 | 2023-04-20 | 再鼎医药(上海)有限公司 | Régulateur dérivé hétérocyclique contenant de l'azote, son procédé de préparation et son utilisation |
| WO2023072188A1 (fr) * | 2021-10-29 | 2023-05-04 | 贝达药业股份有限公司 | Inhibiteurs de kras g12d et leur utilisation en médecine |
| KR20240157684A (ko) | 2022-02-09 | 2024-11-01 | 콴타 테라퓨틱스, 인크. | Kras 조절 인자 및 이의 용도 |
| MX2024010045A (es) * | 2022-02-16 | 2024-08-26 | Amgen Inc | Compuestos de quinazolina y uso de los mismos como inhibidores de proteinas mutantes kras. |
| WO2023159087A1 (fr) * | 2022-02-16 | 2023-08-24 | Amgen Inc. | Composés quinazoline et leur utilisation en tant qu'inhibiteurs de protéines kras mutantes |
| KR20240163107A (ko) | 2022-03-11 | 2024-11-18 | 컴쿼트 바이오사이언시즈 인크. | 헤테로환 화합물 및 이의 용도 |
| TW202345806A (zh) | 2022-03-31 | 2023-12-01 | 美商艾伯維有限公司 | 噻唑并〔５，４－ｂ〕吡啶ｍａｌｔ－１抑制劑 |
| AU2023276596A1 (en) | 2022-05-25 | 2025-01-02 | Quanta Therapeutics, Inc. | Pyrimidine based modulators and uses thereof |
| WO2024008179A1 (fr) * | 2022-07-07 | 2024-01-11 | Beigene, Ltd. | Composés hétérocycliques, compositions à base de ceux-ci et procédés de traitement associés |
| WO2024041621A1 (fr) * | 2022-08-25 | 2024-02-29 | Jacobio Pharmaceuticals Co., Ltd. | Inhibiteurs de protéines mutantes k-ras |
| TW202416976A (zh) * | 2022-09-16 | 2024-05-01 | 大陸商南京明德新藥研發有限公司 | 含六氫螺環［環丙烷—１，２＇—吡咯𠯤］的化合物 |
| WO2024061365A1 (fr) * | 2022-09-22 | 2024-03-28 | 成都奥睿药业有限公司 | Composé pyrimidine à cycle condensé, son procédé de préparation et son utilisation |
| WO2024206766A1 (fr) * | 2023-03-31 | 2024-10-03 | Eli Lilly And Company | Inhibiteurs de kras |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018218070A2 (fr) * | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Inhibiteurs covalents de kras |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010002760A (es) * | 2007-09-12 | 2010-04-01 | Wyeth Llc | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3. |
| JP5934787B2 (ja) * | 2011-05-10 | 2016-06-15 | ギリアード サイエンシーズ， インコーポレイテッド | イオンチャネルモジュレーターとしての縮合複素環式化合物 |
| ES2898765T3 (es) * | 2015-04-10 | 2022-03-08 | Araxes Pharma Llc | Compuestos de quinazolina sustituidos y métodos de uso de los mismos |
| TW202033518A (zh) * | 2018-10-15 | 2020-09-16 | 美商美國禮來大藥廠 | Kras g12c 抑制劑 |
-
2021
- 2021-08-27 JP JP2023513975A patent/JP2023540270A/ja active Pending
- 2021-08-27 EP EP21862890.7A patent/EP4203952A4/fr active Pending
- 2021-08-27 CA CA3191279A patent/CA3191279A1/fr active Pending
- 2021-08-27 WO PCT/US2021/048101 patent/WO2022047260A1/fr unknown
- 2021-08-27 AU AU2021331492A patent/AU2021331492A1/en active Pending
- 2021-08-27 CN CN202180074074.8A patent/CN116368130A/zh active Pending
-
2023
- 2023-02-27 US US18/175,349 patent/US20230331717A1/en active Pending
-
2024
- 2024-07-19 US US18/778,527 patent/US20240383888A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018218070A2 (fr) * | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Inhibiteurs covalents de kras |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022047260A1 (fr) | 2022-03-03 |
| US20240383888A1 (en) | 2024-11-21 |
| US20230331717A1 (en) | 2023-10-19 |
| CN116368130A (zh) | 2023-06-30 |
| JP2023540270A (ja) | 2023-09-22 |
| CA3191279A1 (fr) | 2022-03-03 |
| AU2021331492A1 (en) | 2023-04-13 |
| EP4203952A1 (fr) | 2023-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4203952A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| EP3919483A4 (fr) | Composé de benzopyridone hétérocyclique et son utilisation | |
| EP4101852A4 (fr) | Composé de pyridopyrimidinone et son utilisation | |
| EP3816154A4 (fr) | Composé hétérocyclique et son application | |
| EP4247815A4 (fr) | Composés et leurs utilisations | |
| IL315099A (en) | Heterocyclic compounds and their uses | |
| EP3694861A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| EP3917526A4 (fr) | Composés et leurs utilisations | |
| EP3917934A4 (fr) | Composés et leurs utilisations | |
| EP4096651A4 (fr) | Composés et leurs utilisations | |
| EP3917517A4 (fr) | Composés et leurs utilisations | |
| EP3917529A4 (fr) | Composés et leurs utilisations | |
| EP3753943A4 (fr) | Composé hétérocyclique, son application et composition pharmaceutique le comprenant | |
| IL316285A (en) | Heterocyclic compounds and their uses | |
| EP3952876A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| EP3694509A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| EP3941908A4 (fr) | Composés et leurs utilisations | |
| IL318647A (en) | Heterocyclic compounds and their uses | |
| EP3952875A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| EP3952877A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| EP4037670A4 (fr) | Dérivés de 5-fluoronicotinamide et leurs utilisations | |
| EP4034535A4 (fr) | Composés d'aza-quinoléine et leurs utilisations | |
| EP3914593A4 (fr) | Composés et leurs utilisations | |
| EP3892621A4 (fr) | Composés d'halogénoallylamine et leur utilisation | |
| EP4107154A4 (fr) | Composés hétérocycliques hétéroaryles et leurs utilisations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20230310 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230705 |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40095503 Country of ref document: HK |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20241113 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 417/14 20060101ALI20241107BHEP Ipc: C07D 403/14 20060101ALI20241107BHEP Ipc: C07D 401/14 20060101ALI20241107BHEP Ipc: A61K 31/4375 20060101AFI20241107BHEP |